| Identification | Back Directory | [Name]
Carbamic acid, N-[3-[[5-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]-2-[(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)oxy]phenyl]amino]-3-oxopropyl]-, 9H-fluoren-9-ylmethyl ester | [CAS]
2169723-91-3 | [Synonyms]
Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2-(4-nitrophenyl)carbonate-Fmoc
Carbamic acid, N-[3-[[5-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]-2-[(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)oxy]phenyl]amino]-3-oxopropyl]-, 9H-fluoren-9-ylmethyl ester | [Molecular Formula]
C46H45N3O18 | [MOL File]
2169723-91-3.mol | [Molecular Weight]
927.86 |
| Hazard Information | Back Directory | [Uses]
Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2-(4-nitrophenyl)carbonate-Fmoc (Example 2.28.6) is an ADC linker that can be used to synthesize antibody-conjugated active molecules (ADCs)[1]. | [References]
[1] Lorenzo Benatuil, et al. Anti-cd98 antibodies and antibody drug conjugates. Patent WO2017214456A1. |
|
|